tiprankstipranks
Silexion Therapeutics (SLXN)
NASDAQ:SLXN
US Market
Holding SLXN?
Track your performance easily

Silexion Therapeutics (SLXN) Technical Analysis

21 Followers

Technical Sentiment

Overall Consensus
Neutral
9Bullish
6Neutral
7Bearish
Technical Analysis Consensus
Buy
3Bullish
6Neutral
1Bearish
Moving Average Consensus
Neutral
6Bullish
0Neutral
6Bearish
Silexion Therapeutics’s (SLXN) Moving Averages Convergence Divergence (MACD) indicator is -0.52, suggesting Silexion Therapeutics is a Sell.
Silexion Therapeutics’s (SLXN) 20-Day exponential moving average is 2.72, while Silexion Therapeutics’s (SLXN) share price is $2.79, making it a Buy.
Silexion Therapeutics’s (SLXN) 50-Day exponential moving average is 8.78, while Silexion Therapeutics’s (SLXN) share price is $2.79, making it a Sell.

Silexion Therapeutics (SLXN) Pivot Points

Dec 11, 2024, 07:45 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
1.89
2.22
2.39
2.71
2.88
3.21
3.38
Fibonacci
2.22
2.40
2.52
2.71
2.90
3.02
3.21
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Silexion Therapeutics (SLXN) Moving Averages

Dec 11, 2024, 07:45 AM
Period
Simple
Exponential
MA5
2.75Buy
2.72Buy
MA10
2.56Buy
2.63Buy
MA20
2.43Buy
2.72Buy
MA50
3.31Sell
8.78Sell
MA100
31.76Sell
27.10Sell
MA200
67.12Sell
56.39Sell
Silexion Therapeutics’s (SLXN) 10-Day exponential moving average is 2.63, while Silexion Therapeutics’s (SLXN) share price is $2.79, making it a Buy.
Silexion Therapeutics’s (SLXN) 100-Day exponential moving average is 27.10, while Silexion Therapeutics’s (SLXN) share price is $2.79, making it a Sell.
Silexion Therapeutics’s (SLXN) stock price is $2.79 and Silexion Therapeutics’s (SLXN) 50-day simple moving average is 3.31, creating a Sell signal.
Silexion Therapeutics’s (SLXN) stock price is $2.79 and Silexion Therapeutics’s (SLXN) 100-day simple moving average is 31.76, creating a Sell signal.
Silexion Therapeutics’s (SLXN) stock price is $2.79 and Silexion Therapeutics’s (SLXN) 200-day simple moving average is 67.12, creating a Sell signal.

Silexion Therapeutics (SLXN) Technical Indicators

Dec 11, 2024, 07:45 AM
Name
Value
Implied Action
RSI (14)
43.47
Neutral
STOCH (9,6)
37.41
Neutral
STOCHRSI (14)
37.81
Neutral
MACD (12,26)
-0.52
Sell
ADX (14)
28.08
Neutral
Williams %R
-60.18
Buy
CCI (14)
68.35
Neutral
ATR (14)
0.62
-
Ultimate Oscillator
53.00
Neutral
ROC
18.22
Buy
Silexion Therapeutics’s (SLXN) Relative Strength Index (RSI) is 43.47, creating a Neutral signal.
Silexion Therapeutics’s (SLXN) Trend Strength Indicator (ADX) is 28.08, creating a Neutral signal.
Silexion Therapeutics’s (SLXN) Commodity Channel Index (CCI) is 68.35, creating a Neutral signal.
Silexion Therapeutics’s (SLXN) Price Rate of Change (ROC) is 18.22, creating a Buy signal.

FAQ

Is SLXN a Buy, Hold, or Sell?
Based on SLXN’s technical indicators, SLXN is a Hold.
    What is SLXN’s RSI (14)?
    SLXN’s RSI (14) is 43.47, which suggests SLXN is a Neutral.
      What is SLXN’s MACD?
      SLXN’s MACD is -0.52, which suggests SLXN is a Sell.
        What is SLXN’s 5-day moving average?
        SLXN’s 5-day moving average is 2.75, which suggests SLXN is a Buy.
          What is SLXN’s 20-day moving average?
          SLXN 20-day moving average is 2.43, which suggests SLXN is a Buy.
            What is SLXN’s 50-day moving average?
            SLXN’s 50-day moving average is 3.31, which suggests SLXN is a Sell.
              What is SLXN’s 200-day moving average?
              SLXN’s 200-day moving average is 67.12, which suggests SLXN is a Sell.
                What is SLXN’s Williams % R (14)?
                SLXN’s Williams % R (14) is -60.18, which suggests SLXN is a Buy.
                  What is SLXN’s CCI (14)?
                  SLXN’s CCI (14) is 68.35, which suggests SLXN is a Neutral.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis